School of Biomedical Sciences - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/57545

Filters

2013 1
1
Reset filters

Settings
Statistics
Citations
Author: Mintern, Justine × Author: Villadangos, Jose × Author: MOFFAT, JESSICA × Author: Caminschi, Irina × Start date: 2013 × End date: 2013 ×

Search Results

Now showing 1 - 1 of 1
  • Item
    Thumbnail Image
    Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation
    Moffat, JM ; Segura, E ; Khoury, G ; Caminschi, I ; Cameron, PU ; Lewin, SR ; Villadangos, JA ; Mintern, JD (WILEY-BLACKWELL, 2013-03-01)
    Bone marrow stromal cell-2 (BST-2) has major roles in viral tethering and modulation of interferon production. Here we investigate BST-2 as a receptor for the delivery of antigen to dendritic cells (DCs). We show that BST-2 is expressed by a panel of mouse and human DC subsets, particularly under inflammatory conditions. The outcome of delivering antigen to BST-2 expressed by steady state and activated plasmacytoid DC (pDC) or conventional CD8(+) and CD8(-) DCs was determined. T-cell responses were measured for both MHC class I (MHCI) and MHC class II (MHCII) antigen presentation pathways in vitro. Delivering antigen via BST-2 was compared with that via receptors DEC205 or Siglec-H. We show that despite a higher antigen load and faster receptor internalisation, when antigen is delivered to steady state or activated pDC via BST-2, BST-2-targeted activated conventional DCs present antigen more efficiently. Relative to DEC205, BST-2 was inferior in its capacity to deliver antigen to the MHCI cross-presentation pathway. In contrast, BST-2 was superior to Siglec-H at initiating either MHCI or MHCII antigen presentation. In summary, BST-2 is a useful receptor to target with antigen, given its broad expression pattern and ability to access both MHCI and MHCII presentation pathways with relative efficiency.